Cargando…
Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial
[Image: see text] Drug resistance due to overexpression of membrane transporters in cancer cells and the existence of cancer stem cells (CSCs) is a major hurdle to effective and safe cancer chemotherapy. Nanoparticles have been explored to overcome cancer drug resistance. However, drug slowly releas...
Autores principales: | Wang, Hai, Agarwal, Pranay, Zhao, Gang, Ji, Guang, Jewell, Christopher M., Fisher, John P., Lu, Xiongbin, He, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968444/ https://www.ncbi.nlm.nih.gov/pubmed/29806003 http://dx.doi.org/10.1021/acscentsci.8b00050 |
Ejemplares similares
-
Correction to Overcoming Ovarian Cancer Drug Resistance
with a Cold Responsive Nanomaterial
por: Wang, Hai, et al.
Publicado: (2021) -
Retraction of
“Overcoming Ovarian Cancer Drug
Resistance with a Cold Responsive Nanomaterial”
por: Wang, Hai, et al.
Publicado: (2023) -
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
por: Wang, Hai, et al.
Publicado: (2018) -
Erratum: A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents
por: Wang, Hai, et al.
Publicado: (2016) -
A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of therasnostic agents
por: Wang, Hai, et al.
Publicado: (2015)